BofA analyst Allen Lutz raised the firm’s price target on Doximity (DOCS) to $57 from $54 and keeps a Neutral rating on the shares. The firm believes that Doximity should trade at a premium to healthcare IT peers on a EBITDA multiple basis given a peer topping margin profile and at a discount to Software/Internet peers with more sustainable revenue profiles, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
- Doximity initiated with an Equal Weight at Stephens
- GE Vernova initiated, Merck upgraded: Wall Street’s top analyst calls
- Doximity initiated with a Neutral at Mizuho
- Trump Trade: Autos seen stuck in middle of Trump’s geopolitics
- RFK Jr. impact ‘likely positive’ for Doximity, says Jefferies